SYNDROME OF CHILDREN S HISTAMINE INTOLERANCE
https://doi.org/10.25207/1608-6228-2017-24-4-185-190
Abstract
Aim. The purpose of the study: to pay attention to the urgency of the problem for further deeper study of diseases in children, which is based on the violation of histamine metabolism in the body, namely, increase in the level of extracellular histamine. To study the syndrome of intolerance to histamine (CIS), the diagnosis and treatment of diaminoxidase deficiency (DAO).
Results. Understanding the etiology and pathogenesis of the CIS, studying the diagnosis and treatment of DAO deficiency gives new opportunities in successful treatment, and most importantly prevention of food hypersensitivity in children.
About the Authors
A. V. Burlutskaia
Kuban State Medical University of the Ministry of Health Care of the Russian Federation
Russian Federation
Russian Federation
Department of pediatrics № 2
Corresponding author: Violetta N. Firsova
4 Sedina Street, Krasnodar, 350063; tel.: 8 (918) 443-20-73
V. N. Firsova
Kuban State Medical University of the Ministry of Health Care of the Russian Federation
Russian Federation
Russian Federation
Department of pediatrics № 2
4 Sedina Street, Krasnodar, 350063
References
1. Kamps Antonio Rossel'. Klinicheskie aspekty pitanija i neperenosimosti gistamina u detej s simptomami hronicheskogo narushenija pishhevarenija / Antonio Rossel' Kamps. – Moskva, 2015; 156р.
2. Asher M. L. ISAAC Steering Committee. Clin. Exp. Allergy. 1998. 28 (5): 52 -66.
3. Humbert M. Editorial 100* International Conference of the Amer. Thoracic Society. SCAN. 2004; 3.
4. Asher M. L. International Study of Asthma and Allergies in Childhood (ISAAC).Amer. Thoracic Society.SCAN. 2004; 3.
5. Perederij V.G., Gubskaja E.Ju. Celiakija-samoe chastoe zabolevanie onkoj kishki: Monografija. − Kiev, Vistka; 2013: 112.
6. Gackaja D.A., Korickaja I.V. Dinamika rasprostranennosti allergicheskih zabolevanij sredi detej i molodezhi (rezul'taty pervogo jetapa jepidemiologicheskogo issledovanija). Astma i allergija. 2015; 1: 17-22.
7. Dale H.D., P.D. Laidlaw. The physiological action of βiminazolylethylamine. J. Physiol (London). 1910 (41): 318-344.
8. Maintz L., Bieber T., Novak N. Histamine intolerance in clinical practice. DtschArttebl. 2006; 103 (51-52): 3477-3483.
9. Vlie-Boerstra B.J., van der H.S., Oude Elberink J. N. et al. Mastocytosis and adverse reactionsto biogenic amines and histamine releasing foods: what is the evidence? Neth J. Med. 2005; 63: 244-249.
10. Ring J. Angewandte Allergologie (Implemented allergology). J. Ring. -Munich, Germany: Urban & Vogel, 2004.
11. Maintz L., Novac N. Histamine and histamine intolerance. Clin. Nutr. 2007; 85: 1185-1196.
12. Bieganski T. Biochemical, physiological and pathophysiological aspects of intestinal diamine oxidase. ActaPhysiolo Pol. – 1983. – Vol. 34. -P. 139-154.
13. Cataldi M., Borriello F., Granata F. et al. Histamine receptors and antihistamines: from Discovery to clinical applications. Chem. Imunol. Allergy. 2014; 100: 214-226. 14. Thurmond R.L. The histamine H4 receptors: from orphan to the clinic. Front Pharmacol. 2015. 31 (6): 65.
14. Ellenbroek B.A., Ellenbroek B.A., Ghiabi B. The other side of the histamine H3 receptor. Trends Neurosci. 2014; 37(4): 191-195.
15. Tabarean I.V. Histamine receptor signaling in energy homeostasis. Neuropharmacology. 2015; 21.
16. Komericki P., Klein G., Reider N. et al. Histamine intolerance: lack of reproducibility of single symptoms by oral provocation with histamine: a randomized, double-blind, placebocontrolled cros-over study. Wien KlinWochenschr. 2011; 123(1-2): 15-20.
17. Zampeli E., Tiligada E. The role of histamine H4 receptor in immune and inflammatory disorders. British Journal of Pharmacology. 2009; 157: 24-33.
18. Dejl M.M., Formen Dzh.K. Rukovodstvo po immunofarmakologii. − Moskva: Medicina, 1998; 332.
19. Colome Rivero G., Tormo Carnicer R., Rosell Camps A. et al. Diaminooxidase low levels and paediatric gastrointestinal pathology. 47Th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. 9-12 June 2014. Jerusalem, Israel.
20. Steinbrecher I. Histamin und Kopfschmerz. Allergologie. 2005; 28: 84-91.
21. Verma A., Deb D.K., Sassano A. et al. Cutting edge: activation of the p38 mitogen activated protein kinase signaling pathway mediates cytokineinducedhemopoietic suppression in aplastic anemia. J. Immunol. 2002; 168: 5984-5988.
22. Black A.K. Unusual urticarias. J. Dermatol. 2001; 28(11): 632-634.
23. Arock M., Valent P. Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives. Expert Rev. Hematol. 2010; 3: 497-516.
24. Jadid-Niaragh F., Mirshafiey A. Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis. Neuropharmacology. 2010; 59: 180-189.
25. Kofler H., Aberrer W., Deibi M. et al. Diamine oxidase (DAO) serum activity: not a useful marker for diagnosis of histamine intolerance. Allergologie. 2009; 32: 105-109.
26. Music E., Korosec P., Silar M. et al. Serum diamineoxidasa activity as a diagnostic test for histamine intolerance. Wien Kin Wochenschr. 2013; 125(9-10): 239-43.
27. Schwelberger H.G. Histamine intolerance: overestimated or underestimated. Inflamm Res. 2009; 58(1): 51-52.
Review
For citations:
Burlutskaia A.V., Firsova V.N. SYNDROME OF CHILDREN S HISTAMINE INTOLERANCE. Kuban Scientific Medical Bulletin. 2017;(4):185-190. (In Russ.) https://doi.org/10.25207/1608-6228-2017-24-4-185-190
Views:
1005
Email this article 